WinstonWınston
Back
New Nordic Healthbrands AB logo

New Nordic Healthbrands AB

NNH.ST
47
Household & Personal Products · Consumer Defensive
Exchange
Stockholm Stock Exchange
Winston Score
47
Winston is serious
Mixed quality — meaningful strengths and weaknesses.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Weak
Growth
Strong
Cash Flow
Mixed
Stability
Strong
Valuation
Good
Dividends
Weak

Winston Score History

The full picture

New Nordic Healthbrands is a Swedish consumer health company that makes and sells dietary supplements, vitamins, and wellness products. Its brands include tablets and capsules targeting areas like hair growth, sleep, weight management, and general health. The company sells mainly to everyday consumers through pharmacies, health stores, and supermarkets across Europe and beyond.

The company earns money by selling packaged health products directly to retailers, who then sell them to shoppers. New Nordic operates primarily in Scandinavia but also has a presence in other European markets and select international regions. Its competitive position relies on recognizable brand names and established retail shelf space, though it faces intense competition from larger supplement makers and private-label products. With thin operating margins around 1.5% and a low return on invested capital, the main risk is that rising input costs or pricing pressure from competitors could further squeeze profitability.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+14.5% YoY

YoY Growth Rate

Steady revenue growth

EPS Growth

+247.1% YoY

YoY Growth Rate

EPS growth accelerating

Insider Activity

44.6%ownership

Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

kr 10M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Company generates more cash than it spends — no dilution risk from fundraising

Growth + cash flow

New Nordic Healthbrands AB is a rare growth stock that's already generating positive cash flow while growing at 15%. The Winston Score doesn't fully credit this transition from "burner" to "earner."

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
5.5%
Thin — 5.5% gross margin
Profit after running costs
Operating Margin
5.5%
Thin — 5.5% operating margin
Return on the money invested
ROCE
9.6%
Below par — 9.6% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+3.5%
Slow sales growth (+3.5% YoY)
Profit growth
EPS YoY
+58.7%
Earnings growing fast (+58.7% YoY)

Earnings growing 25%+ a year. The compounder zone.

How steady the profit is
EPS Consistency
6/8 quarters
Earnings grew in most of the last 8 quarters

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
71%
Modest — 71% of profit becomes cash
Spare cash per sale
FCF Margin
0.9%
Thin free cash flow (0.9%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.34
Conservative — low debt load (0.34)
Covers its interest
Interest Cover
6.75x
Adequate interest coverage (6.8x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
14.4x
no trend
Attractive valuation — P/E 14.4

P/E in the normal range. Price is roughly $15 for every $1 of yearly profit.

Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
1.29%
no trend
Small dividend — 1.29% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend record
Dividend Growth
N/A
no trend
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial